|
1
|
West KA, Castillo SS and Dennis PA:
Activation of the PI3K/Akt pathway and chemotherapeutic resistance.
Drug Resist Updat. 5:234–248. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Staal SP: Molecular cloning of the akt
oncogene and its human homologues AKT1 and AKT2: Amplification of
AKT1 in a primary human gastric adenocarcinoma. Proc Natl Acad Sci
USA. 84:5034–5037. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hanks SK and Hunter T: Protein kinases 6.
The eukaryotic protein kinase superfamily: Kinase (catalytic)
domain structure and classification. FASEB J. 9:576–596.
1995.PubMed/NCBI
|
|
4
|
Zinda MJ, Johnson MA, Paul JD, Horn C,
Konicek BW, Lu ZH, Sandusky G, Thomas JE, Neubauer BL, Lai MT and
Graff JR: AKT-1, −2, and −3 are expressed in both normal and tumor
tissues of the lung, breast, prostate, and colon. Clin Cancer Res.
7:2475–2479. 2001.PubMed/NCBI
|
|
5
|
Jeong SJ, Pise-Masison CA, Radonovich MF,
Park HU and Brady JN: Activated AKT regulates NF-kappaB activation,
p53 inhibition and cell survival in HTLV-1-transformed cells.
Oncogene. 24:6719–6728. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Song G, Ouyang G and Bao S: The activation
of Akt/PKB signaling pathway and cell survival. J Cell Mol Med.
9:59–71. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lindsley CW, Zhao Z, Leister WH, Robinson
RG, Barnett SF, Defeo-Jones D, Jones RE, Hartman GD, Huff JR, Huber
HE and Duggan ME: Allosteric Akt (PKB) inhibitors: Discovery and
SAR of isozyme selective inhibitors. Bioorg Med Chem Lett.
15:761–764. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Cherrin C, Haskell K, Howell B, Jones R,
Leander K, Robinson R, Watkins A, Bilodeau M, Hoffman J, Sanderson
P, et al: An allosteric Akt inhibitor effectively blocks Akt
signaling and tumor growth with only transient effects on glucose
and insulin levels in vivo. Cancer Biol Ther. 9:493–503. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Pietrobon EO, Domínguez LA, Vincenti AE,
Burgos MH and Fornés MW: Detection of the mouse acrosome reaction
by acid phosphatase. Comparison with chlortetracycline and electron
microscopy. J Androl. 22:96–103. 2001.PubMed/NCBI
|
|
10
|
Visconti PE, Bailey JL, Moore GD, Pan D,
Olds-Clarke P and Kopf GS: Capacitation of mouse spermatozoa. I.
Correlation between the capacitation state and protein tyrosine
phosphorylation. Development. 121:1129–1137. 1995.PubMed/NCBI
|
|
11
|
Barret AJ and Heath MF: Lysosomal enzymes.
Lysosomes: A Laboratory Handbook. Dingle JT: (2nd).
Elsevier/North-Holland Biomedical Press. (Amsterdam). 19–145.
1977.
|
|
12
|
Belmonte SA, Challa A, Gutierrez LS,
Bertini F and Sosa MA: alpha-Mannosidase from rat epididymal fluid
is a ligand for phosphomannosyl receptors on the sperm surface. Int
J Androl. 21:277–282. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Aarons D, Boettger-Tong H, Holt G and
Poirier GR: Acrosome reaction induced by immunoaggregation of a
proteinase inhibitor bound to the murine sperm head. Mol Reprod
Dev. 30:258–264. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Fichorova R and Anderson DJ: Use of sperm
viability and acrosomal status assays in combination with
immunofluorescence technique to ascertain surface expression of
sperm antigens. J Reprod Immunol. 20:1–13. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Banihani S, Agarwal A, Sharma R and
Bayachou M: Cryoprotective effect of L-carnitine on motility,
vitality and DNA oxidation of human spermatozoa. Andrologia.
46:637–641. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lan A and Du J: Potential role of Akt
signaling in chronic kidney disease. Nephrol Dial Transplant.
30:385–394. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sajithlal GB, Hamed HA, Cruickshanks N,
Booth L, Tavallai S, Syed J, Grant S, Poklepovic A and Dent P:
Sorafenib/regorafenib and phosphatidyl inositol 3 kinase/thymoma
viral proto-oncogene inhibition interact to kill tumor cells. Mol
Pharmacol. 84:562–571. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hu C, Dadon T, Chenna V, Yabuuchi S,
Bannerji R, Booher R, Strack P, Azad N, Nelkin BD and Maitra A:
Combined Inhibition of Cyclin-Dependent Kinases (Dinaciclib) and
AKT (MK-2206) Blocks Pancreatic Tumor Growth and Metastases in
Patient-Derived Xenograft Models. Mol Cancer Ther. 14:1532–1539.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Conti AI, Santoni M, Amantini C, Burattini
L, Berardi R, Santoni G, Cascinu S and Muzzonigro G: Progress of
molecular targeted therapies for advanced renal cell carcinoma.
Biomed Res Int. 2013:4191762013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Gonzalez-Angulo AM, Krop I, Akcakanat A,
Chen H, Liu S, Li Y, Culotta KS, Tarco E, Piha-Paul S,
Moulder-Thompson S, et al: SU2C phase Ib study of paclitaxel and
MK-2206 in advanced solid tumors and metastatic breast cancer. J
Natl Cancer Inst. 107:pii: dju4932015. View Article : Google Scholar
|
|
21
|
Fraser LR: Requirements for successful
mammalian sperm capacitation and fertilization. Arch Pathol Lab
Med. 116:345–350. 1992.PubMed/NCBI
|
|
22
|
Naz RK and Rajesh PB: Role of tyrosine
phosphorylation in sperm capacitation/acrosome reaction. Reprod
Biol Endocrinol. 2:752004. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Suarez SS: Control of hyperactivation in
sperm. Hum Reprod Update. 14:647–657. 2008. View Article : Google Scholar : PubMed/NCBI
|
